282 related articles for article (PubMed ID: 22184469)
1. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.
Grim SA; Berger K; Teng C; Gupta S; Layden JE; Janda WM; Clark NM
J Antimicrob Chemother; 2012 Mar; 67(3):707-14. PubMed ID: 22184469
[TBL] [Abstract][Full Text] [Related]
2. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
3. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
4. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
8. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
[TBL] [Abstract][Full Text] [Related]
9. Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study.
van Hal SJ; Chen SC; Sorrell TC; Ellis DH; Slavin M; Marriott DM
J Antimicrob Chemother; 2014 Aug; 69(8):2210-4. PubMed ID: 24788656
[TBL] [Abstract][Full Text] [Related]
10. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
Yenigün Koçak B; Kuloğlu F; Doğan Çelik A; Akata F
Mikrobiyol Bul; 2011 Jul; 45(3):489-503. PubMed ID: 21935782
[TBL] [Abstract][Full Text] [Related]
12. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.
Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Lepe-Jiménez JA
J Antimicrob Chemother; 2013 Jan; 68(1):206-13. PubMed ID: 22945914
[TBL] [Abstract][Full Text] [Related]
13. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
14. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
[TBL] [Abstract][Full Text] [Related]
18. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia.
Kim SH; Yoon YK; Kim MJ; Sohn JW
J Antimicrob Chemother; 2013 Dec; 68(12):2890-7. PubMed ID: 23825380
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.
Chalmers C; Gaur S; Chew J; Wright T; Kumar A; Mathur S; Wan WY; Gould IM; Leanord A; Bal AM
Mycoses; 2011 Nov; 54(6):e795-800. PubMed ID: 21615542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
